Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug–drug interactions among HIV‐positive patients receiving treatment for coronavirus disease 2019 (COVID‐19)

Objectives The aim of this international multicentre study was to review potential drug–drug interactions (DDIs) for real‐life coadministration of combination antiretroviral therapy (cART) and coronavirus disease 2019 (COVID‐19)‐specific medications. Methods The Euroguidelines in Central and Eastern...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2022-07, Vol.23 (6), p.693-700
Hauptverfasser:	Lakatos, Botond, Kowalska, Justyna, Antoniak, Sergii, Gokengin, Deniz, Begovac, Josip, Vassilenko, Anna, Wasilewski, Piotr, Fleischhans, Lukas, Jilich, David, Matulionyte, Raimonda, Kase, Kerstin, Papadopoulus, Antonios, Rukhadze, Nino, Harxhi, Arjan, Hofman, Sam, Dragovic, Gordana, Vasyliev, Marta, Verhaz, Antonija, Yancheva, Nina, Oprea, Cristiana
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiviral agents combination antiretroviral therapy coronavirus disease 2019 (COVID‐19) Coronaviruses Corticoids Corticosteroids COVID-19 Drug interactions drug–drug interaction Emtricitabine Health services HIV Human immunodeficiency virus Hydroxychloroquine Integrase Interleukin 1 receptor antagonist Lamivudine Non-nucleoside reverse transcriptase inhibitors Nucleoside reverse transcriptase inhibitors Observational studies Patients Protease inhibitors Proteinase inhibitors Respiratory diseases RNA-directed DNA polymerase Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Steroid hormones Tenofovir Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!